SCHEMBL4494385

SCHEMBL4494385

CCC=CCCC1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4494378 1.00
SCHEMBL5513303 1.00
SCHEMBL11886523 1.00
SCHEMBL4494386 1.00
SCHEMBL20624832 0.98 ALDH1A1 (0.41)
SCHEMBL2322130 0.87 ALDH1A1 (0.40)
SCHEMBL13883684 0.85 ALDH1A1 (0.54)
SCHEMBL4476946 0.82 ALDH1A1 (0.56)
SCHEMBL4476952 0.82 ALDH1A1 (0.56)
SCHEMBL4479334 0.82 ALDH1A1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115023478-A Polishing composition 日本瓦姆&珀巴尔株式会社 2022-09-06 CN disclosed
CN-109824904-B Modified MQ silicon resin and preparation method and application thereof 万华化学集团股份有限公司 2021-09-03 CN disclosed
CN-109824904-A A kind of modified MQ silicone resin and its preparation method and application 万华化学集团股份有限公司 2019-05-31 CN disclosed
US-7612106-B2 Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof ARENA PHARMACEUTICALS, INC. (US) 2009-11-03 US disclosed
US-20090258892-A1 FUSED PYRAZOLE DERIVATIVES AND METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2009-10-15 US disclosed
EP-1831178-A2 FUSED PYRAZOLE DERIVATIVES AND USES THEREOF IN METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERS Arena Pharmaceuticals, Inc. (US) 2007-09-12 EP disclosed
US-7241792-B2 Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof ARENA PHARMACEUTICALS, INC. (US) 2007-07-10 US disclosed
US-20070073062-A1 Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof ARENA PHARMACEUTICALS, INC. 2007-03-29 US disclosed
US-20060205955-A1 Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof ARENA PHARMACEUTICALS, INC. (US) 2006-09-14 US disclosed
WO-2006069242-A2 FUSED PYRAZOLE DERIVATIVES AND USES THEREOF IN METHODS OF TREATMENT OF METABOLIC-RELATED?DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2006-06-29 WO disclosed
CN-1045202-C Process for making 1,3-diols and 3-hydroxyaldehydes SHELL INT RESEARCH (NL) 1999-09-22 CN disclosed
EP-0682650-B1 PROCESS FOR MAKING 1,3-DIOLS AND 3-HYDROXYALDEHYDES SHELL INT RESEARCH (NL) 1998-05-20 EP disclosed
CN-1117289-A Process for making 1,3-diols and 3-hydroxyaldehydes SHELL INT RESEARCH (NL) 1996-02-21 CN disclosed
EP-0682650-A1 PROCESS FOR MAKING 1,3-DIOLS AND 3-HYDROXYALDEHYDES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1995-11-22 EP disclosed
US-5344993-A Catalytic hydroformylation of epoxides with di-tert-phosphines SHELL OIL COMPANY (US) 1994-09-06 US disclosed
WO-1994018149-A1 PROCESS FOR MAKING 1,3-DIOLS AND 3-HYDROXYALDEHYDES SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1994-08-18 WO disclosed
EP-0263403-B1 NOVEL MICROORGANISM AND METHOD FOR PRODUCING OXYGENOUS COMPOUNDS WITH SAID MICROORGANISM IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-04-21 EP disclosed
EP-0263403-A2 Novel microorganism and method for producing oxygenous compounds with said microorganism IDEMITSU KOSAN COMPANY LIMITED (JP) 1988-04-13 EP disclosed